@farmerbob or anyone else (Beaza) what multiple would we command of our current shareprice if we obtain 2mg/kg twice weekly and trial metrics that only require an approx 40 mill USD (required for stage 2 of phase 3), that leaves the options open to apply for Accelerated Approval designation at the conclusion of stage 2. And acknowledgement of the mri and biomarker data pointing at a future DMOAD label. With 50 mill USD covered by the first tranche of a regional deal in April 2024
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.005(1.89%) |
Mkt cap ! $111.1M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 29.0¢ | 26.5¢ | $362.3K | 1.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31811 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 42377 | 3 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| PAR (ASX) Chart |